Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C

This publication has 25 references indexed in Scilit:

• Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
  Published by Elsevier ,2001
• A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis C
  Hepatology, 2001
• Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis
  New England Journal of Medicine, 2000
• Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
  New England Journal of Medicine, 2000
• Impact of Interferon Alfa–2B and Ribavirin on Progression of Liver Fibrosis in Patients With Chronic Hepatitis C
  Hepatology, 2000
• The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
  New England Journal of Medicine, 1999
• Modeling the Hepatitis C Virus Epidemic in France
  Hepatology, 1999
• Rising Incidence of Hepatocellular Carcinoma in the United States
  New England Journal of Medicine, 1999
• Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view
  Gastroenterology, 1999
• Natural history of liver fibrosis progression in patients with chronic hepatitis C
  The Lancet, 1997